Publications

Publications (individuals under my direct supervision are underlined):

  • Feilotter, H.E., Michel, C., P. Uy, L. Bathurst, and S. DAVEY (2014). “BRCA1 haploinsufficiency leads to altered expression of genes involved in cellular proliferation and development.” PLoS One 9, e100068
  • Kelly, R. and S. DAVEY (2013). “Tousled-like kinase-dependent phosphorylation of Rad9 plays a role in cell cycle progression and G2/M checkpoint exit.” PLoS One 8, e85859.
  • Haslehurst, A.M., M. Koti, M. Dharsee, P. Nuin, K. Evans, J. Geraci, T. Childs, J. Chen, J. Li, J. Weberpals, S. DAVEY, J. Squire, P.C. Park, and H. Feilotter (2012). “EMT transcription factors snail and slug directly contribute to cisplatin resistance in serous epithelial ovarian cancer.” BMC Cancer 12, 91.
  • Greer-Card, D.A., M. Sierant, and S. DAVEY (2010). " Rad9A is required for the G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition." J. Biol. Chem. 285, 15653-61.
  • Sierant, M.L., N. Archer, and S. DAVEY (2010). “The Rad9A checkpoint protein is required for nuclear localization of the claspin adaptor protein.” Cell Cycle 9, 548-56.
  • Singh, V., S. Nurmohamed, S. DAVEY, and Z. Jia (2007). "Tri-cistronic cloning, overexpression and purification of human Rad9, Rad1, Hus1 protein complex." Protein Expr. Purif. 54, 204-11.
  • Pandita, R., G.S. Sharma, A. Laszlo, K.M. Hopkins, S. DAVEY, M. Chakhparonian, R.J. Wellinger, S.N. Powell, J.L. RotiRoti, H.B. Lieberman, and T. Pandita (2006). “Mammalian Rad9 plays a role in telomere stability, S- and G2-specific cell survival and homologous recombinational repair.” Mol. Cell. Biol. 26, 1850-64.
  • Bedard, L., M. Alessi, S. DAVEY, and T. Massey (2005). “Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and rat.” Cancer Res. 65, 1265-70.
  • Fraser, J.L.A., E. Neill, and S. DAVEY. (2003) “Fission yeast Uve1 and Apn2 function in distinct oxidative damage repair pathways in vivo.” DNA Repair 2, 1253-67.
  • Greer, D.A., B.D.A. Besley, K. Kennedy, and S. DAVEY (2003). “hRad9 binds double strand breaks is required for damage-dependent TopBP1 focus formation.” Cancer Res. 63, 4829-35.
  • St. Onge, R.P., B.D.A. Besley, J. Pelley, and S. DAVEY (2003). “A role for the phosphorylation of hRad9 in checkpoint signalling.” J. Biol. Chem. 278, 26620-8.
  • St.Onge, R.P., B.D.A. Besley, M. Park, R. Casselman, and S. DAVEY (2001). “DNA damage-dependent and -independent phosphorylation of the hRad9 checkpoint protein.” J. Biol. Chem. 276, 41898-905.
  • Kaur, B., J.L.A. Fraser, G.A. Freyer, S. DAVEY, and P.W. Doetsch (1999). "A Uve1p-mediated mismatch repair pathway in Schizosaccharomyces pombe." Mol. Cell. Biol. 19, 4703-10.
  • St. Onge, R.P., C.M. Udell, R. Casselman, and S. DAVEY (1999). "The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1." Mol. Biol. Cell. 10, 1985-95.
  • Hang, H., S. J. Rauth, K.M. Hopkins, S. DAVEY, and H.B. Lieberman (1998). "Molecular cloning and tissue-specific expression of Mrad9, a murine orthologue of the Schizosaccharomyces pombe rad9+ checkpoint control gene." J. Cell. Physiol. 177, 232-40.
  • Udell, C.M., S.K. Lee, and S. DAVEY (1998). “HRAD1 and MRAD1 encode mammalian homologues of the fission yeast rad1+ cell cycle checkpoint control gene.” Nucleic Acids Res. 26, 3971-8.
  • DAVEY, S., C. Han, S.A. Ramer, J.C. Klassen, A. Jacobson, A. Eisenberger, K.M. Hopkins, H.B. Lieberman, and G.A. Freyer (1998). “Fission yeast rad12+ regulates cell cycle checkpoint control, and is homologous to the Bloom’s syndrome disease gene.” Mol. Cell. Biol. 18, 2721-8.
  • DAVEY, S., M.L. Nass, J.V. Ferrer, K. Sidik, A. Eisenberger, D.L. Mitchell, and G.A. Freyer (1997). “The fission yeast UVDR DNA repair pathway is inducible.” Nucleic Acids Res. 25, 1002-8.
  • Lieberman, H.B., K.M. Hopkins, M. Nass, D. Demetrick, and S. DAVEY (1996). “A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.” Proc. Natl. Acad. Sci. USA 93, 13890-5.
  • DAVEY, S., and D. Beach (1995). “RACH2, a novel human gene which complements a fission yeast cell cycle checkpoint mutation.” Mol. Biol. Cell 6, 1411-21.
  • Freyer, G.A., S. DAVEY, J.V. Ferrer, A.M. Martin, D. Beach, and P.W. Doetsch (1995). "An alternative eukaryotic DNA excision repair pathway." Mol. Cell. Biol. 15, 4572-7.
  • Walworth, N., S. DAVEY, and D. Beach (1993). "Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2." Nature 363, 368-71.
  • DAVEY, S., and E.A. Faust. (1990) "Murine DNA polymerase α-primase initiates RNA-primed DNA synthesis preferentially upstream of a 3'-CC(C/A)-5' motif." J. Biol. Chem. 265, 3611-4.
  • DAVEY, S., and E.A. Faust. (1990) "Murine DNA polymerase α fills gaps to completion in a direct assay. Altered kinetics of de novo DNA synthesis at single nucleotide gaps." J. Biol. Chem. 265, 4098-4104.
  • Faust, E.A., R. Nagy, and S. DAVEY (1985). "Mouse DNA polymerase α-primase terminates and reinitiates DNA synthesis 2-14 nucleotides upstream of C2A1-2(C2-3/T2) sequences on a minute virus of mice DNA template." Proc. Natl. Acad. Sci. USA 82: 4023-7.